These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32816870)

  • 1. Performance and costs of multiple screening strategies for type 2 diabetes: two population-based studies in Shanghai, China.
    Li Y; Jiang H; Cheng M; Yao W; Zhang H; Shi Y; Xu W
    BMJ Open Diabetes Res Care; 2020 Aug; 8(1):. PubMed ID: 32816870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining glycosylated hemoglobin A1c and fasting plasma glucose for diagnosis of type 2 diabetes in Chinese adults.
    Mo M; Zhong W; Zhao G; Ruan Y; Zhang H; Shi L; Lu D; Yang Q; Li Y; Jiang Q; Li R; Xu WH
    BMC Endocr Disord; 2013 Oct; 13():44. PubMed ID: 24099651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycated hemoglobin independently or in combination with fasting plasma glucose versus oral glucose tolerance test to detect abnormal glycometabolism in acute ischemic stroke: a Chinese cross-sectional study.
    Wu S; Shi Y; Pan Y; Li J; Jia Q; Zhang N; Zhao X; Liu G; Wang Y; Wang Y; Wang C
    BMC Neurol; 2014 Sep; 14():177. PubMed ID: 25209629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
    Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
    Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test: Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry.
    Ferrannini G; De Bacquer D; Gyberg V; De Backer G; Kotseva K; Mellbin LG; Risebrink R; Tuomilehto J; Wood D; Rydén L
    Diabetes Res Clin Pract; 2022 Jan; 183():109156. PubMed ID: 34843858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal cut-off points of fasting plasma glucose for two-step strategy in estimating prevalence and screening undiagnosed diabetes and pre-diabetes in Harbin, China.
    Bao C; Zhang D; Sun B; Lan L; Cui W; Xu G; Sui C; Wang Y; Zhao Y; Wang J; Li H
    PLoS One; 2015; 10(3):e0119510. PubMed ID: 25785585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).
    Perry RC; Shankar RR; Fineberg N; McGill J; Baron AD;
    Diabetes Care; 2001 Mar; 24(3):465-71. PubMed ID: 11289469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative type 2 diabetes screening tests may reduce the number of U.S. adults with undiagnosed diabetes.
    Dadwani RS; Skandari MR; GoodSmith MS; Phillips LS; Rhee MK; Laiteerapong N
    Diabet Med; 2020 Nov; 37(11):1935-1943. PubMed ID: 32449198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical Analysis on Threshold of Haemoglobin A1C (HBA1c) for Diabetes Diagnosis and the Relationship Between HBA1c and Plasma Glucose Concentrations in Chinese Diabetic High-Risk Groups.
    Li X; Bao C; Zhao Y; Song H; Wang W
    Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
    Jesudason DR; Dunstan K; Leong D; Wittert GA
    Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects.
    Ko GT; Chan JC; Tsang LW; Cockram CS
    Diabetes Care; 2000 Dec; 23(12):1770-3. PubMed ID: 11128350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of type 2 diabetes mellitus using fasting plasma glucose and HbA1c levels among individuals with impaired fasting plasma glucose: a cross-sectional study in Thailand.
    Sitasuwan T; Lertwattanarak R
    BMJ Open; 2020 Nov; 10(11):e041269. PubMed ID: 33172945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal cut-off points for two-step strategy in screening of undiagnosed diabetes: a population-based study in China.
    Ye Z; Cong L; Ding G; Yu M; Zhang X; Hu R; Wu J; Fang L; Wang H; Zhang J; He Q; Su D; Zhao M; Wang L; Gong W; Xiao Y; Liang M; Pan J
    PLoS One; 2014; 9(3):e87690. PubMed ID: 24609110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of two screening methods for undiagnosed diabetes in China: an cost-effectiveness study.
    Zhang Y; Sun J; Pang Z; Gao W; Sintonen H; Kapur A; Qiao Q
    Prim Care Diabetes; 2013 Dec; 7(4):275-82. PubMed ID: 24021478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Fasting Plasma Glucose and Postprandial Urine Glucose in Screening for Diabetes in Chinese High-risk Population.
    Yang BQ; Lu Y; He JJ; Wu TZ; Xie ZL; Lei CH; Zhou Y; Han J; Bian MQ; You H; Mei DX; Sun ZL
    Chin Med J (Engl); 2015 Dec; 128(24):3270-5. PubMed ID: 26668139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.
    Davidson MB; Schriger DL; Peters AL; Lorber B
    JAMA; 1999 Apr; 281(13):1203-10. PubMed ID: 10199430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting plasma glucose and risk factor assessment: Comparing sensitivity and specificity in identifying gestational diabetes in urban black African women.
    Dickson LM; Buchmann EJ; Janse van Rensburg C; Norris SA
    S Afr Med J; 2019 Dec; 110(1):21-26. PubMed ID: 31865938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.
    Narayan KM; Hanson RL; Pettitt DJ; Bennett PH; Knowler WC
    Diabetes Care; 1996 Sep; 19(9):972-8. PubMed ID: 8875091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.